Award

Upregulation of Autophagy by Tet3-mediated 5-methylcytosine oxidation – Relevance to Parkinson's Disease

Description: An abnormally folded version of the protein alpha-synuclein forms characteristic clumps (Lewy bodies) in nerve cells in Parkinson's disease (PD). One possible reason for this is an age-related decrease in enzymes that degrade (break down) alpha-synuclein and are involved in the lysosome-autophagy system (LAS). During aging, changes in DNA methylation (the process of regulating gene expression) have been suggested to turn "off" LAS genes. This study focuses on TET3, an enzyme that can maintain its original methylation pattern and keep LAS genes turned "on." We predict that TET3 is reduced in aging, thereby increasing the risk for alpha-synuclein accumulation and PD, and that novel therapies can prevent this from occurring.
Funding type: research
Funder scheme: Target Advancement Program
Start date: 2016-01-01
End date: 2016-12-31
Investigator: Gerd Pfeifer (lead)
Institution: Center for Epigenetics
Field: Medicine
Funded outputs count: 0
Funder award ID: mjff-upregulation-autophagy-tet3-mediated-5-methylcytosine-oxidation-relevance-parkinsons-disease
OpenAlex ID: G6136189860